Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02945969 · ClinicalTrials.gov registry record · Phase 3
Sodium Lowering and Urinary Protein Reduction Trial
A Phase 3 study, sponsored by Tulane University School of Public Health and Tropical Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 151
- Enrollment target
NCT02945969 is a Phase 3 study that has completed, run by Tulane University School of Public Health and Tropical Medicine. The registered enrollment target is 151 participants.
The verdict
NCT02945969, a Phase 3 study, has completed, sponsored by Tulane University School of Public Health and Tropical Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 151 participants
- Enrollment target
Study Summary
The proposed randomized controlled trial will test the effect of dietary sodium reduction on albuminuria in patients with proteinuric chronic kidney disease. Results from this study will clarify the role of dietary sodium reduction in management of patients with proteinuric chronic kidney disease and its potential to halt the progression of chronic kidney disease.
Interventions
- BEHAVIORAL Low Sodium Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2016-11 |
| Est. Completion | 2021-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02945969
The ClinicalTrials.gov registry entry for NCT02945969 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University School of Public Health and Tropical Medicine, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low Sodium Diet is the first listed.
NCT02945969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02945969 about?
NCT02945969 is a clinical study titled "Sodium Lowering and Urinary Protein Reduction Trial". The proposed randomized controlled trial will test the effect of dietary sodium reduction on albuminuria in patients with proteinuric chronic kidney disease. Results from this study will clarify the role of dietary sodium reduction in management of patients with proteinuric chronic kidney disease an...
What is the current status of trial NCT02945969?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 151 participants. The study started on 2016-11. Estimated completion is 2021-01.
What interventions are being tested in trial NCT02945969?
The interventions under investigation include: Low Sodium Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT02945969?
This trial is sponsored by Tulane University School of Public Health and Tropical Medicine, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.